Pfizer 2014 Annual Report Download - page 38

PFIZER ANNUAL REVIEW 2014 www.pzer.com/annual 38
ANNUAL REVIEW 2014
Our Business > Corporate and Shareholder Information
STOCK LISTINGS
The principal market for our Common Stock is the New York Stock
Exchange (NYSE). Our stock is also listed on the NYSE Euronext
Brussels Exchange, the London Stock Exchange and the SIX Swiss
Stock Exchange, as well as various United States regional
stock exchanges.
STOCK TRANSFER AGENT
AND REGISTRAR
Computershare
P.O. Box 30170
College Station, TX 77842-3170
Telephone: [phone]
Outside the U.S., Canada and
Puerto Rico: 1-781-575-4591
Internet: www.computershare.com
SHAREHOLDER SERVICES
AND PROGRAMS
Please contact our Stock Transfer Agent and Registrar with inquiries
concerning shareholder accounts of record and stock transfer matters,
and also for information on the following services and programs:
Computershare Investment Program
• Direct purchase of Pzer stock
• Dividend reinvestment
• Automatic monthly or bi-monthly investments
Book-entry share ownership
Direct deposit of dividends
FORWARD-LOOKING INFORMATION
This Annual Review includes forward-looking statements about,
among other things, our anticipated future operating and nancial
performance, business plans and prospects, and products and
product candidates that are subject to substantial risks and
uncertainties that could cause actual results to differ materially from
those expressed or implied by such statements. Please refer to
Pzer’s Annual Report on Form 10-K for the year ended
December 31, 2014, and Pzer’s subsequent reports on Form
CORPORATE AND
SHAREHOLDER INFORMATION
10-Q, including the sections thereof captioned “Risk Factors” and
“Forward-Looking Information That May Affect Future Results,” as
well as Pzer’s subsequent reports on Form 8-K for a description
of the substantial risks and uncertainties related to the forward-
looking statements included in this Annual Review. These reports are
available on our website at www.pzer.com and on the U.S. Securities
and Exchange Commission’s (SEC) website at www.sec.gov. The
forward-looking statements in this Annual Review speak only as of the
original date of this Annual Review and we undertake no obligation to
update or revise any of these statements, except as required by law or
the rules and regulations of the SEC.
POLITICAL ACTION COMMITTEE (PAC)
To review our most recent PAC and corporate political contributions
report, go online at www.pzer.com/pac.
HELPLINES
Patients, customers and health care professionals who have
questions about any of our products should call 1-800-438-1985.
Patients in the U.S. who need help getting access to their Pzer
medicines should contact Pzer RxPathways.® The program provides
eligible patients with a range of support services including insurance
counseling, co-pay help, providing Pzer medicines for free or at a
savings, and more. Pzer RxPathways is a joint program of Pzer Inc.
and the Pzer Patient Assistance Foundation.™ Visit
www.PzerRxPathways.com or call 1-866-706-2400 to learn more.
ADDITIONAL INFORMATION
You can nd more information about Pzer online at www.pzer.com.
You can follow us on Twitter at www.Twitter.com/Pzer. You can also
visit us on Facebook at www.facebook.com/Pzer and on LinkedIn at
www.linkedin.com/company/Pzer.
This Annual Review is produced by Pzer’s Corporate Affairs group.
Unless otherwise noted herein, the trademarks, logos and service
marks appearing in the Annual Review, whether or not appearing with
the trademark symbol, are owned or licensed by Pzer Inc or
its afliates.
Design: Ideas On Purpose, New York
CORPORATE AND SHAREHOLDER INFORMATION